Binding of serum amyloid P-component (SAP) by amyloid fibrils
- PMID: 118839
- PMCID: PMC1537850
Binding of serum amyloid P-component (SAP) by amyloid fibrils
Abstract
Serum amyloid P-component (protein SAP) was found to bind in vitro to isolated amyloid fibrils of both primary and secondary types. The binding was strictly calcium-dependent, optimal uptake requiring at least 0.5 mM calcium ion. Using normal human serum as the source of protein SAP different fibril preparations became saturated with between 5--20 micrograms of SAP per mg dry weight of fibril. Isolated pure protein SAP bound in greater amounts. In control experiments SAP did not bind significantly to collagen fibrils, sheep erythrocytes, plastic shavings, or the following immobilized proteins: human kappa or lambda Bence-Jones proteins; human; rabbit or mouse IgG; human serum albumin. C-reactive protein, which resembles protein SAP structurally but has calcium-dependent specificity for different ligands, bound significantly to only one of five different amyloid fibril preparations.
Similar articles
-
Agglutination of complement-coated erythrocytes by serum amyloid P-component.J Immunol. 1981 Mar;126(3):1217-9. J Immunol. 1981. PMID: 7462631
-
Isolation and characterization of C-reactive protein and serum amyloid P component in the rat.Immunology. 1982 Jan;45(1):55-70. Immunology. 1982. PMID: 7056568 Free PMC article.
-
Binding of human serum amyloid P-component to phosphocholine.Arch Biochem Biophys. 1994 Nov 1;314(2):337-43. doi: 10.1006/abbi.1994.1451. Arch Biochem Biophys. 1994. PMID: 7979374
-
Pathogenesis, diagnosis and treatment of systemic amyloidosis.Philos Trans R Soc Lond B Biol Sci. 2001 Feb 28;356(1406):203-10; discussion 210-1. doi: 10.1098/rstb.2000.0766. Philos Trans R Soc Lond B Biol Sci. 2001. PMID: 11260801 Free PMC article. Review.
-
[Amyloid P components in normal human skin and skin with lesions].Hautarzt. 1988 Nov;39(11):712-6. Hautarzt. 1988. PMID: 3072321 Review. German.
Cited by
-
Reactive (secondary) amyloidosis and its pathogenesis.Rheumatol Int. 1984;5(1):1-7. doi: 10.1007/BF00541358. Rheumatol Int. 1984. PMID: 6084866 Review.
-
The Development of Serum Amyloid P as a Possible Therapeutic.Front Immunol. 2018 Oct 16;9:2328. doi: 10.3389/fimmu.2018.02328. eCollection 2018. Front Immunol. 2018. PMID: 30459752 Free PMC article. Review.
-
Immunofluorescence study of amyloid P-component patterns in human nephropathies.Histochemistry. 1982;74(3):347-54. doi: 10.1007/BF00493434. Histochemistry. 1982. PMID: 6179901
-
Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction.Ann Rheum Dis. 2004 Jul;63(7):831-5. doi: 10.1136/ard.2002.004796. Ann Rheum Dis. 2004. PMID: 15194579 Free PMC article.
-
Protection against prolonged pneumococcal infection involves structural changes in C-reactive protein and subsequent binding to both phosphocholine and amyloids on the bacterial surface.Front Immunol. 2025 Jul 16;16:1631409. doi: 10.3389/fimmu.2025.1631409. eCollection 2025. Front Immunol. 2025. PMID: 40740789 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous